Lactic Acid Bacteria as Mucosal Immunity Enhancers and Antivirals through Oral Delivery
Open Access
- 26 October 2022
- journal article
- review article
- Published by MDPI AG in Applied Microbiology
- Vol. 2 (4) , 837-854
Abstract
Mucosal vaccination offer an advantage over systemic inoculation from the immunological viewpoint. The development of an efficient vaccine is now a priority for emerging diseases such as COVID-19, that was declared a pandemic in 2020 and caused millions of deaths globally. Lactic acid bacteria (LAB) especially Lactobacillus are the vital microbiota of the gut, which is observed as having valuable effects on animals’ and human health. LAB produce lactic acid as the major by-product of carbohydrate degradation and play a significant role in innate immunity enhancement. LAB have significant characteristics to mimic pathogen infections and intrinsically possess adjuvant properties to enhance mucosal immunity. Increasing demand and deliberations are being substantially focused on probiotic organisms that can enhance mucosal immunity against viral diseases. LAB can also strengthen their host’s antiviral defense system by producing antiviral peptides, and releasing metabolites that prevent viral infections and adhesion to mucosal surfaces. From the perspectives of “one health” and the use of probiotics, conventional belief has opened up a new horizon on the use of LAB as antivirals. The major interest of this review is to depict the beneficial use of LAB as antivirals and mucosal immunity enhancers against viral diseases.Keywords
Funding Information
- National Key R&D Program of China (2021YFD1801403)
This publication has 115 references indexed in Scilit:
- Probiotic Lactobacillus rhamnosus GG mono-association suppresses human rotavirus-induced autophagy in the gnotobiotic piglet intestineGut Pathogens, 2013
- Mechanisms of Action of AdjuvantsFrontiers in Immunology, 2013
- In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxideBMC Infectious Diseases, 2011
- Potentials of Exopolysaccharides from Lactic Acid BacteriaIndian Journal of Microbiology, 2011
- Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathwaysProceedings of the National Academy of Sciences, 2010
- Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll‐like receptor‐2‐dependent mechanismImmunology, 2010
- Evaluation of adhesion capacity, cell surface traits and immunomodulatory activity of presumptive probiotic Lactobacillus strainsInternational Journal of Food Microbiology, 2010
- S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functionsProceedings of the National Academy of Sciences, 2008
- Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein onLactobacillus caseiInduces Neutralizing Antibodies in MiceJournal of Virology, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006